E815
TEAS SECTION 8 & 15 RECEIVED
07/31/2026
Back to search
Official data from USPTO
XCOPRI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/31/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
06/21/2019
Registration date
08/11/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2020
Last transaction
07/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
05/11/2020
First use in commerce
05/11/2020
Drawing code
3
Owner type
03
Owner location
Seongnam-si, KR
Examiner
AGREDA, SAMANTHA LEIGH
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.
Holders and representatives
Holders
SK BIOPHARMACEUTICALS CO., LTD.
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes and veterinary preparations for treatment of central nervous system diseasescancer and metabolic diseases; biochemical preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for pharmaceutical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; medical preparation of trace elements for human and animal usefor the treatment of central nervous system diseasescancer and metabolic diseases; biotechnological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medicinal purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medical or veterinary purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; pharmaceutical preparations for immunity adjustment; therapeutic drugs and agents for the treatment of central nervous system diseasescancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases
Publications
History of USPTO decisions and trademark events.
31 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/07/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/28/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/28/2020
IUAF
USE AMENDMENT FILED
05/11/2020
EISU
TEAS STATEMENT OF USE RECEIVED
05/11/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2019
ALIE
ASSIGNED TO LIE
12/11/2019
ALIE
ASSIGNED TO LIE
12/06/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/27/2019
DOCK
ASSIGNED TO EXAMINER
10/07/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/16/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/16/2019
CNSL
SUSPENSION LETTER WRITTEN
09/16/2019
DOCK
ASSIGNED TO EXAMINER
09/12/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2019
NWAP
NEW APPLICATION ENTERED
06/25/2019
Continuous trademark protection
Get notified about every new filing that threatens XCOPRI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.